The study, published March 11 in Cancer, analyzed patterns between patients with metabolic syndrome diagnoses and newly-onset cancers in the group, which included 44,115 participants.
The association between metabolic syndrome and cancer risk was elevated, even more so when signs of chronic inflammation were present. Increased risk was associated with higher likelihood of developing associated with subsequent breast, endometrial, colorectal and liver cancers.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
